5Galazka AM. Robertson SE, Kraigher A. Mumps and mumps vaceine: a global review[J]. Bulletin WHO, 1999,77(1):3-12.
6Schlipkoter U, Muhlberger N, Kries RV, et al, Surveillance of measles-mumps-rubella vaccine-associated aseptic meningitis in Germany[J]. Infection, 2003,30 (6) : 351-355.
7Fernandez de la Hoz Zeitler K, Garcia Colmenero C, Puchades Belenguer, et al. Mumps epidemic in the health area of Toledo with immunization intervention. Estimation of vaccine effectiveness[J].Med Clin (Bare), 1997, 108(5):175-179.
8Miteheu LA,Jing LEA J, Decarie M, et al. Serological respose to measles, mupipc and rubella(MMR) vaceine in heahhy infants failure to respond to meales and mumps components may influence dceision on timing of the second dose of MMR[J]. Canj Public Heahh, 1998,89 (5) : 325.
9Gut JP, Lablache C, Behr S, et al. Symptomatic mumps virus reinfections[J] .J Med Virol, 1995,45(1):17-23.
